The Good Shepherd Community clinic provides free health, dental, and optical care for those who don't have insurance. The clinic has seen a lot of growth since they first got started in 1995, but Vanesa Ramsey, executive director of the clinic, says in the last three years the number of patients coming in for care has sky-rocketed.
"I feel like with the economy like it is, I feel like that our patient load will continue to grow. Until we are at capacity, and we really don't know what the capacity is at this point," Ramsey said.
Ramsey says they provide service to about 3,000 patients, and that in this year alone there's been over 8,000 office visits.
She says they estimate they give the community about four-million dollars in services.
"We also take a load off the emergency room here," Ramsey said.
The clinic has a staff of about 20, and they say while it's hard to keep up with the increase in patients they'll do whatever it takes to keep providing service.
"It's my way of giving back to others," Margaret Scifres, a nurse practitioner, said.
The staff says it's a rewarding job, and that they want people to know they're there to help.
"If somebody needs to be seen, if they need medical care then this is a good place to come," Scifres said.
Study found more germs and a wider variety of bacterial types in houses with dogs
But it's unclear what the finding might mean for patients
Hopelessness, disability may play a role in feelings of despair, study finds
But questions remain about widespread screening
Patients thought to have lung condition were re-evaluated in small study
NEW YORK (AP) — The nation's record-low teen birth rate stems from robust declines in nearly every state, but most dramatically in several Mountain States and among Hispanics, according to a new government report.
WARSAW, Poland (AP) — A 33-year-old Polish man received a face transplant just three weeks after being disfigured in a workplace accident, in what his doctors said Wednesday is the fastest time frame to date for such an operation. It was Poland's first face transplant.
By Julie Steenhuysen CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer. Jansen's next vaccine success could come by taming the superbug MRSA, a drug-resistant bacterium that she has seen ravage a healthy man up close and personally. Methicillin-resistant Staphylococcus aureus infects an estimated 53 million people globally and costs more than $20 billion a year to treat. ...